Search results for "co-infection"

showing 10 items of 26 documents

Evaluating polymicrobial immune responses in patients suffering from tick-borne diseases

2018

Abstract There is insufficient evidence to support screening of various tick-borne diseases (TBD) related microbes alongside Borrelia in patients suffering from TBD. To evaluate the involvement of multiple microbial immune responses in patients experiencing TBD we utilized enzyme-linked immunosorbent assay. Four hundred and thirty-two human serum samples organized into seven categories followed Centers for Disease Control and Prevention two-tier Lyme disease (LD) diagnosis guidelines and Infectious Disease Society of America guidelines for post-treatment Lyme disease syndrome. All patient categories were tested for their immunoglobulin M (IgM) and G (IgG) responses against 20 microbes assoc…

Lyme DiseaseCoinfectionco-infectionsBorrelialcsh:Rlcsh:MedicinezoonoositinfektiotCD57 AntigensImmunoglobulin MROC CurveTick-Borne DiseasesborrelioosiArea Under CurveBorrelia burgdorferiImmunoglobulin GimmuunivasteLymen borrelioosiHumanslcsh:Qlcsh:ScienceinfektiotauditScientific Reports
researchProduct

Food provisioning alters infection dynamics in populations of a wild rodent

2015

While pathogens are often assumed to limit the growth of wildlife populations, experimental evidence for their effects is rare. A lack of food resources has been suggested to enhance the negative effects of pathogen infection on host populations, but this theory has received little investigation. We conducted a replicated two-factor enclosure experiment, with introduction of the bacteriumBordetella bronchisepticaand food supplementation, to evaluate the individual and interactive effects of pathogen infection and food availability on vole populations during a boreal winter. We show that prior to bacteria introduction, vole populations were limited by food availability.Bordetella bronchisept…

Male0106 biological sciencesRodentPopulation Dynamicsfood supplementation01 natural sciencesRodent Diseases2300 General Environmental ScienceRandom Allocation2400 General Immunology and MicrobiologyPathogenResearch ArticlesFinlandGeneral Environmental Science0303 health sciencesBordetella bronchisepticabiologyArvicolinaeEcologyGeneral Medicinefactorial experimentcoBordetellaArvicolinaeFemalepopulation limitationSeasonsGeneral Agricultural and Biological Sciences10184 Institute of Veterinary Pathology1100 General Agricultural and Biological SciencesBordetella bronchiseptica010603 evolutionary biologyGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciencesco-infection1300 General Biochemistry Genetics and Molecular Biologybiology.animalAnimalsPopulation Growthta413Bordetella Infections030304 developmental biologyGeneral Immunology and MicrobiologyHost (biology)biology.organism_classificationinfectionDietBordetella InfectionsvoleDietary Supplements570 Life sciences; biologyta1181VoleProceedings of the Royal Society B: Biological Sciences
researchProduct

Community-acquired respiratory virus lower respiratory tract disease in allogeneic stem cell transplantation recipient: Risk factors and mortality fr…

2018

Abstract Risk factors (RFs) and mortality data of community‐acquired respiratory virus (CARVs) lower respiratory tract disease (LRTD) with concurrent pulmonary co‐infections in the setting of allogeneic hematopoietic stem cell transplantation (allo‐HSCT) is scarce. From January 2011 to December 2017, we retrospectively compared the outcome of allo‐HSCT recipients diagnosed of CARVs LRTD mono‐infection (n = 52, group 1), to those with viral, bacterial, or fungal pulmonary CARVs LRTD co‐infections (n = 15, group 2; n = 20, group 3, and n = 11, group 4, respectively), and with those having bacterial pneumonia mono‐infection (n = 19, group 5). Overall survival (OS) at day 60 after bronchoalveol…

Male0301 basic medicinemedicine.medical_treatmentcommunity acquired respiratory virusHematopoietic stem cell transplantationBronchoalveolar LavageGastroenterology0302 clinical medicineRisk Factorsrespiratory virus co‐infectionsLungRespiratory Tract Infectionsmedicine.diagnostic_testRespiratory tract infectionsCoinfectionHematopoietic Stem Cell TransplantationMiddle AgedCommunity-Acquired InfectionsInfectious Diseasesmedicine.anatomical_structureVirusesvirus-bacterial mixed infectionsRespiratory virusFemaleOriginal Articlerespiratory virus co-infectionsBronchoalveolar Lavage FluidAdultmedicine.medical_specialtyvirus‐bacterial mixed infections030106 microbiologyContext (language use)CMV DNAemiaAntiviral Agents03 medical and health sciencesInternal medicinemedicineHumansTransplantation Homologousallogeneic hematopoietic stem cell transplantationAgedRetrospective StudiesTransplantationLungBacteriabusiness.industryFungiBacterial pneumoniaOriginal Articlesmedicine.diseaseTransplantationBronchoalveolar lavagebusinessimmunodeficiency score index030215 immunology
researchProduct

Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

2019

AbstractBackgroundAlcohol consumption is a known risk factor for liver disease in HIV-infected populations. Therefore, knowledge of alcohol consumption behaviour and risk of disease progression associated with hazardous drinking are important in the overall management of HIV disease. We aimed at assessing the usefulness of routine data collected on alcohol consumption in predicting risk of severe liver disease (SLD) among people living with HIV (PLWHIV) with or without hepatitis C infection seen for routine clinical care in Italy.MethodsWe included PLWHIV from two observational cohorts in Italy (ICONA and HepaICONA). Alcohol consumption was assessed by physician interview and categorized ac…

Male030508 substance abuseHIV InfectionsSeverity of Illness IndexCohort StudiesLiver disease0302 clinical medicineRisk FactorsEpidemiologyMedicineHIV InfectionAlcohol consumptionAlcohol consumption HIV-infected HIV/HCV co-infection Severe liver disease030212 general & internal medicineeducation.field_of_studyCoinfectionLiver Diseaselcsh:Public aspects of medicineLiver DiseasesHazard ratioHepatitis CMiddle AgedHepatitis CItalyalcohol consumption; HIV-infected; HIV/HCV co-infection; severe liver diseaseCoinfectionFemale0305 other medical scienceHumanCohort studyResearch ArticleAdultmedicine.medical_specialtyAlcohol DrinkingPopulationSevere liver diseaseHIV/HCV co-infectionNO03 medical and health sciencesEnvironmental healthHumansRisk factorAlcohol consumption; HIV-infected; HIV/HCV co-infection; Severe liver disease; Adult; Alcohol Drinking; Cohort Studies; Female; HIV Infections; Hepatitis C; Humans; Italy; Liver Diseases; Male; Middle Aged; Risk Factors; Severity of Illness Index; CoinfectioneducationHIV-infectedbusiness.industryRisk FactorPublic Health Environmental and Occupational Healthlcsh:RA1-1270medicine.diseaseCohort StudiebusinessBMC Public Health
researchProduct

Natural populations of Spodoptera exigua are infected by multiple viruses that are transmitted to their offspring

2014

Sublethal infections by baculoviruses (Baculoviridae) are believed to be common in Lepidoptera, including Spodoptera exigua. In addition, novel RNA viruses of the family Iflaviridae have been recently identified in a laboratory population of S. exigua (S. exigua iflavirus-1: SeIV-1; S. exigua iflavirus-2: SeIV-2) that showed no overt signs of disease. We determined the prevalence of these viruses in wild populations and the prevalence of co-infection by the different viruses in shared hosts. Infection by S. exigua multiple nucleopolyhedrovirus (SeMNPV) and iflaviruses in S. exigua adults (N= 130) from horticultural greenhouses in southern Spain was determined using qPCR and RT-PCR based tec…

MaleBaculoviridaefood.ingredientOffspringPopulationSpodopteraSpodopteraSeMNPVLepidoptera genitaliafoodExiguaPrevalenceAnimalsRNA VirusesAdult infectioneducationPest Control BiologicalEcology Evolution Behavior and Systematicseducation.field_of_studybiologyIflavirusAlphabaculovirusbiology.organism_classificationVirologyNucleopolyhedrovirusesCo-infectionAlphabaculovirusIflaviridaeSpainFemale
researchProduct

Prevalence and predictors of malaria in human immunodeficiency virus infected patients in beira, mozambique

2018

Co-infection between malaria and HIV has major public health implications. The aims of this study were to assess the malaria prevalence and to identify predictors of positivity to malaria Test in HIV positive patients admitted to the health center S&atilde

MalePediatricsHealth Toxicology and MutagenesisHuman immunodeficiency virus (HIV)lcsh:MedicineHIV InfectionsComorbiditymedicine.disease_causeSettore MED/42 - Igiene Generale E Applicata0302 clinical medicinecotrimoxazole prophylaxisRetrospective StudiePrevalenceHIV Infection030212 general & internal medicineYoung adultCotrimoxazole prophylaxiMozambiqueMedical attentionvirus diseasesMiddle AgedMalaria predictors in developing countrieMalaria prevalenceFemalepsychological phenomena and processesHumanAdultmedicine.medical_specialtyTuberculosis030231 tropical medicineArticleHIV-malaria co-infection03 medical and health sciencesmental disordersparasitic diseasesmedicineHumansmalaria predictors in developing countriesRetrospective StudiesCross-Sectional Studiebusiness.industryPublic healthlcsh:RPublic Health Environmental and Occupational HealthHIVmedicine.diseaseComorbidityMalariaCross-Sectional StudiesHiv patientsbusinessMalaria
researchProduct

Burden and viral aetiology of influenza-like illness and acute respiratory infection in intensive care units

2015

The purpose of this investigation was to study the viral aetiology of influenza-like illness (ILI) and acute respiratory tract infection (ARTI) among patients requiring intensive care unit admission. A cross-sectional retrospective study was carried out in Sicily over a 4-year period. A total of 233 respiratory samples of patients with ILI/ARTI admitted to intensive care units were molecularly analyzed for the detection of a comprehensive panel of aetiologic agents of viral respiratory infections. About 45% of patients was positive for at least one pathogen. Single aetiology occurred in 75.2% of infected patients, while polymicrobial infection was found in 24.8% of positive subjects. Influe…

MalePediatricsSettore MED/42 - Igiene Generale E Applicatalaw.invention0302 clinical medicinelawInfluenza-like illness030212 general & internal medicineChildSicilyRespiratory Tract InfectionsAcute respiratory tract infectionAged 80 and overIntensive care unitsRespiratory tract infectionsCoinfectionMortality rateAge FactorsRespiratory infectionMiddle AgedIntensive care unitCo-infectionCo-infection; Influenza-like illness; Intensive care units; Italy; Sicily; Viral infection; Microbiology; Immunology; Infectious DiseasesInfectious DiseasesItalyVirus DiseasesChild PreschoolCoinfectionFemaleAdultmedicine.medical_specialtyAdolescentImmunologyMicrobiologyArticleYoung Adult03 medical and health sciencesIntensive caremedicineHumansIntensive care unitRetrospective StudiesInfluenza-like illneInfluenza-like illnessbusiness.industryInfant NewbornInfantmedicine.diseaseSurvival AnalysisCross-Sectional Studies030228 respiratory systemViral infectionbusinessMicrobes and Infection
researchProduct

Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients – French ANRS CO13 HEPAVIH cohort

2017

International audience; Background & aims: There is little data available on the use of new oral direct-acting antiviral (DAA) regimens to treat human immunodeficiency virus and hepatitis C virus (HIV/HCV) co-infected patients in real-life settings. Here, the efficacy and safety of all-oral DAA-based regimens in HIV/HCV-co-infected patients enrolled in the French nationwide ANRS CO13 HEPAVIH observational cohort are reported.Methods: HIV/HCV-co-infected patients enrolled in the ANRS CO13 HEPAVIH observational cohort were included if they began an all-oral DAA-based regimen before 1st May 2015 (12-week regimens) or 1st February 2015 (24-week regimens). Treatment success (SVR12) was defined b…

Malemedicine.medical_specialtyHepatitis C virus[SDV]Life Sciences [q-bio]Integrase inhibitorHIV Infectionsmedicine.disease_causeAntiviral AgentsHIV/HCV co-infectionCohort Studies03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicineparasitic diseasesmedicineHumans030212 general & internal medicineAdverse effectHepatologyReverse-transcriptase inhibitorbusiness.industryCoinfectionRibavirinvirus diseasesHepatitis C ChronicMiddle Aged[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences3. Good healthRegimenSustained virological responseLogistic ModelschemistryImmunologyCohort030211 gastroenterology & hepatologyFemaleAll-oral DAAbusinessCohort studymedicine.drug
researchProduct

Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (C…

2019

Background and aims Limited data are available on the effectiveness and tolerability of direct-acting antivirals (DAAs) therapies in the real world for HCV-infected patients with comorbidities. This study aimed to describe the effectiveness of OBV/PTV/r +/- DSV (3D/2D regimen) with or without ribavirin (RBV) in HCV or HCV/HIV co-infected patients with GT1/GT4 and CKD (IIIb-V stages), including those under hemodialysis and peritoneal dialysis in routine clinical practice in Spain in 2015. Material and methods Non-interventional, retrospective, multicenter data collection study in 31 Spanish sites. Socio-demographic, clinical variables, study treatment characteristics, effectiveness and toler…

Malemedicine.medical_treatmentHIV InfectionsHepacivirus0302 clinical medicine:Infections::Virus Diseases::Hepatitis Viral Human::Hepatitis C::Hepatitis C Chronic [DISEASES]ribavirina2-Naphthylaminemediana edad:virosis::infecciones por virus ARN::infecciones por Retroviridae::infecciones por Lentivirus::infecciones por VIH [ENFERMEDADES]ancianoSulfonamidesCoinfectionfarmacoterapiaLiver Diseasesvirus diseasesValineInfeccions per VIH - TractamentCirrhosisNephrology/drug therapyMedicine030211 gastroenterology & hepatologyDrug Therapy Combinationinsuficiencia renalmedicine.medical_specialty:virosis::hepatitis viral humana::hepatitis C::hepatitis C crónica [ENFERMEDADES]GenotypeProlineSciencecompuestos macrocíclicosSurgical and Invasive Medical ProceduresGastroenterology and HepatologyAntiviral AgentsMicrobiologyUrinary System ProceduresPeritoneal dialysis03 medical and health sciencesDrug TherapyHumansLost to follow-upRenal Insufficiency ChronicUracilAgedRetrospective StudiesFlavivirusesanilidasOrganismsOrgan Transplantationmedicine.diseasedigestive system diseasesRegimenchemistryHIV-1Malalties del ronyóCarbamatesgenotipoCyclopropanesRNA virusesantivíricosSustained Virologic ResponsePhysiologyhumanoschemistry.chemical_compoundChronic Kidney DiseaseMedicine and Health SciencesRenal TransplantationAnilidesRenal Insufficiency030212 general & internal medicinePathology and laboratory medicinecoinfecciónMultidisciplinaryKidney diseasesHepatitis C virus:Infections::Infections::Virus Diseases::RNA Virus Infections::Retroviridae Infections::Lentivirus Infections::Infections::Virus Diseases::HIV Infections [DISEASES]resultado del tratamientoQR:Infections::Coinfection [DISEASES]Middle AgedMedical microbiologyHepatitis CTreatment OutcomeInfectious DiseasesTolerabilityResearch DesigncarbamatosVirusesFemaleHemodialysisPathogensVIH-1Research ArticleGlomerular Filtration RateMacrocyclic CompoundsClinical Research DesignLactams MacrocyclicResearch and Analysis MethodssulfonamidasRenal DialysisInternal medicineRibavirinMedical DialysismedicineDialysisTransplantationRenal Physiology/tratamiento farmacológicoRitonavirBiology and life sciencesbusiness.industryRibavirinestudios retrospectivosViral pathogensHepatitis C ChronicHepatitis virusesMicrobial pathogens:enfermedades parasitarias::coinfección [ENFERMEDADES]Spaindiálisis renalCo-InfectionsPhysical therapyinfecciones por VIHAdverse EventsbusinessHepatitis C - TractamenturaciloKidney diseasePLoS ONE
researchProduct

Occurrence of a case of influenza A(H1N1)pdm09 and B co-infection during the epidemic season 2012–2013

2013

Abstract We report the detection of one case of co-infection with influenza A(H1N1)pdm09 and B, occurred during the 2012–2013 influenza season in Sicily. The dual infection was identified in a 18-year-old boy, who was not covered by specific vaccination and who had no other pre-existing risk factors. He presented classical symptoms of influenza-like illness developing no respiratory complications. A(H1N1)pdm09 viral concentration was initially about 10-fold higher than B virus, whereas its clearance was more rapidly achieved than in the case of B virus infection. Although influenza co-infection appears to be a rare event, a continued influenza surveillance activity is recommended, in order …

Microbiology (medical)Malemedicine.medical_specialtyRespiratory complicationsAdolescentMolecular Sequence DataBiologyInfluenza BSettore MED/42 - Igiene Generale E ApplicataMicrobiologyVirusInfluenza A Virus H1N1 SubtypeInfluenza HumanGeneticsmedicineInfluenza-like illnessHumansMolecular BiologySicilyEcology Evolution Behavior and SystematicsEpidemic seasonCoinfectionCo-infection Influenza; A(H1N1)pdm09; Influenza B; Influenza-like illnessPublic healthvirus diseasesInfluenza aVirologyVaccinationInfluenza B virusCo-infection InfluenzaInfectious DiseasesA(H1N1)pdm09ImmunologyEpidemiological MonitoringHuman mortality from H5N1Co infection
researchProduct